Please login to read the full article.
Scrip Regulatory Affairs
Synthon and Generics rulings and the scope of the SPC Regulation in the EU: a creative approach or a step too far?
16 September 2011
Maria Isabel Manley and Marina Vickers
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU court opinion on Losec case a blow for originator firms
- European court decisions on SPCs gives drug combinations more protection
- Top European court confirms validity of negative term SPCs ? welcome news for pharma industry
- "Messy compromise" on combo SPCs in EU could increase thickets and litigation
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
